Trial Information
Hypofractionated Ion Irradiation (Carbon Ions Versus Protons) of the Prostate
Inclusion Criteria:
histological proven carcinoma of the prostate with Gleason score risk of lymphe node
involvement of <15% calculated by the Yale-formula; Risk [%] = [GS -5] x [PSA/3 + 1.5 x
T], mit T = 0, 1, and 2 for cT1c, cT2a, und cT2b/cT2c
- Karnofsky-Index ≥ 70%
- age between 40 and 80 years
- PSA
Exclusion Criteria:
Stadium IV (distant metastases) Lymphogenous Metastases hip replacement former irradiation
of the pelvis pacemaker defibrillator
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
proctitis and cystitis
Outcome Description:
via incidence grade 3-4 toxicity (NCI-CTC-AE)
Outcome Time Frame:
3 years
Safety Issue:
No
Authority:
Germany: Ethics Commission
Study ID:
IPI
NCT ID:
NCT01641185
Start Date:
May 2012
Completion Date:
May 2015
Related Keywords:
- Exposure to Artificially Accelerated Beams of Ionized Particles Generated by Synchrotrons
- Prostatic Neoplasms
- prostate
- IPI
- hypofractionation
- carbon ions
- proton
- Neoplasms
- Prostatic Neoplasms